ALSPW Spineway SAS

SPINEWAY : Minutes of the General Meeting of April 2, 2026

SPINEWAY : Minutes of the General Meeting of April 2, 2026

Ecully, April 7, 2026 – 8:00 a.m.

SPINEWAY

Minutes of the General Meeting of April 2, 2026

The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on first notice on Thursday 2 April 2026 at 10.00 am at the company’s registered office, 7 allée Moulin Berger in Ecully (69).

The defaulting shareholders were represented by SELARL TULIER POLGE ALIREZAI, as ad hoc representative appointed by Order of the President of the Lyon Commercial Court dated February 24, 2026. The number of shares held by shareholders present, represented and voting by mail was 35 544 391, representing 100% of voting rights. The quorum having been reached, the Meeting was able to proceed and deliberate normally.

All the resolutions put forward at this Combined General Meeting were approved, with the exception of Resolution No. 17, on the recommendation of the Board of Directors.

Stéphane Le Roux, CEO of Spineway, said: “I would like to thank all our shareholders for their participation and support, which endorse our ambitions and confirm their confidence in the Group’s growth strategy.”

Information relating to the Combined General Meeting is available on the Company’s website under “Investors/Regulated Information”: .

Next event:

April 30, 2026 – First-quarter 2026 revenue

About Spineway

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.

Spineway has an international network of over 50 independent distributors and more than 70% of its revenue comes from exports.

Spineway is eligible for the PEA-PME (equity savings plans for SMEs)

Listing venue: Euronext Growth Paris

ISIN: FR001400N2P2

Ticker: ALSPW

Find out all about Spineway at

Contacts:

Spineway

Shareholder-services line

Available Tuesday through Thursday (10 a.m.-12 midday)

08 06 70 60 60

Aelium

Investor relations

Solène Kennis                                      

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.

Attachment



EN
07/04/2026

Underlying

ALSPWSpineway SAS

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Spineway SAS

 PRESS RELEASE
Free
ALSPW SPINEWAY SAS

SPINEWAY : Minutes of the General Meeting of April 2, 2026

SPINEWAY : Minutes of the General Meeting of April 2, 2026 Ecully, April 7, 2026 – 8:00 a.m. SPINEWAY Minutes of the General Meeting of April 2, 2026 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on first notice on Thursday 2 April 2026 at 10.00 am at the company’s registered office, 7 allée Moulin Berger in Ecully (69). The defaulting shareholders were represented by SELARL TULIER POLGE ALIREZAI, as ad hoc representative appointed by Order of the President of the Lyon Commercial Court dated February 24, 2026. The number of shares held by s...

April 7, 2026 1 EN
 PRESS RELEASE
Free
ALSPW SPINEWAY SAS

SPINEWAY : Compte-rendu de l’Assemblée Générale du 2 avril 2026

SPINEWAY : Compte-rendu de l’Assemblée Générale du 2 avril 2026 Ecully, le 7 avril 2026 – 8h00 SPINEWAY Compte-rendu de l’Assemblée Générale du 2 avril 2026 L'Assemblée Générale Mixte (Ordinaire et Extraordinaire) des actionnaires de Spineway s'est tenue sur première convocation ce jeudi 2 avril 2026 à 10 heures au siège social de la société, 7 allée Moulin Berger à Ecully (69). Les actionnaires défaillants ont été représentés par la SELARL TULIER POLGE ALIREZAI, en qualité de mandataire ad hoc nommé par Ordonnance du Président du Tribunal de commerce de Lyon en date du 24 février 20...

April 7, 2026 1 EN
 PRESS RELEASE
Free
ALSPW SPINEWAY SAS

Spineway : 2025 annual results

Spineway : 2025 annual results Ecully, February 17, 2026 – 7:00 p.m. SPINEWAY2025 annual results Revenue up 4%Improved resultsStronger growth potential Condensed consolidated income statement20252024Pro forma* 2024ReportedIn thousands of euros Revenue12,43011,950 11,950Cost of sales-3,783-3,699 -3,699Gross margin 8,6478,250 8,250% of revenue69,6%69,0% 69%Net operating expenses-10,780-10,227 -9,131Of which external expenses-3,967-3,522 -3,646Of which personnel expenses-4,600-4,890 -4,890     Of which other op. income and expenses-1,436-920 -358Of which dep., amort., and provisions-777-895 ...

February 17, 2026 1 EN
 PRESS RELEASE
Free
ALSPW SPINEWAY SAS

SPINEWAY : Résultats annuels 2025

SPINEWAY : Résultats annuels 2025 Ecully, le 17 février 2026 – 18h30 SPINEWAY Résultats annuels 2025 Un chiffre d’affaires en progression de + 4%Une amélioration des résultatsUn potentiel de croissance renforcé Compte de résultat consolidé résumé20252024Proforma* 2024PubliéEn milliers d'euros Chiffre d'affaires12 43011 950 11 950Coût des ventes-3 783-3 699 -3 699Marge brute8 6478 250 8 250% du CA69,6%69,0% 69%Coûts nets d’exploitation-10 780-10 227 -9 131Dont charges externes-3 967-3 522 -3 646Dont charges de personnel-4 600-4 890 -4 890     Dont autres pdts et ch. d'exploitation-1 43...

February 17, 2026 1 EN
 PRESS RELEASE
Free
ALSPW SPINEWAY SAS

SPINEWAY : 2025 revenue of €12.4 million,  with an acceleration of sal...

SPINEWAY : 2025 revenue of €12.4 million,  with an acceleration of sales in Q4 2025 (+34%) Ecully, January 13, 2026 – 6:30 p.m. SPINEWAY 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%) In thousands of euros20252024Change as a %H1 revenue5,5736,535-15%H2 revenue6,8575,415+27%Full-year revenue12,43011,950+4% Unaudited consolidated data In the final quarter of 2025, Spineway, a specialist in innovative implants for the treatment of severe spine disorders, benefited from an acceleration in sales across all of its markets and the receipt of key account orders d...

January 13, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch